ÂÜÀòÂÒÂ×

The Research and Development team at AnimaBiotech is responsible for advancing the mRNA Lightning platform to discover selective small molecule mRNA drugs. The team, composed of scientists specializing in oncology, early discovery, image analysis, high content screening, neurodegeneration, and computational biology, collaborates to explore and elucidate the mechanisms of action of these novel therapeutics. Their comprehensive research efforts drive the innovation and development of new mRNA drugs targeting a variety of therapeutic areas.